Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Erythromycin ethyl succinate 200 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin ethylsuccinate 100 mg/2.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin ethylsuccinate 400mg/5mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin ethylsuccinate 200mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin ethylsuccinate 100mg/2.5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin ethylsuccinate 400mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Erythromycin ethylsuccinate + sulfisoxazole acetyl ns/ns suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing erythromycin ethylsuccinate and sulfafurazole acetyl |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing erythromycin ethylsuccinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin ethylsuccinate 400 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin (as erythromycin ethyl succinate) 25 mg/mL oral suspension |
Has precise active ingredient |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin ethyl succinate 200 mg chewable tablet |
Has precise active ingredient |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin ethyl succinate 200 mg chewable tablet |
Has basis of strength substance (attribute) |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Erythromycin (as erythromycin ethyl succinate) 400 mg oral tablet |
Has precise active ingredient |
True |
Erythromycin ethylsuccinate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |